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Viral Proteases: Evolution of Minireview
Diverse Structural Motifs
to Optimize Function
in the design of antiviral agents. This focus has resulted
in a wealth of new information on the structure and
function of these enzymes.
Several viral proteases will be described here that
exemplify the diversity of structures and biological func-
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constellations of active-site residues, and unique allo-
steric mechanisms. Though not comprehensive, the fol-
lowing are some of the more striking examples of how
There is more than one way to cleave a peptide bond, viral proteases achieve and regulate their function dur-
and viral proteases are revealing many new strategies ing the multistep process of viral replication and matu-
for accomplishing the feat. As information on the three- ration.
dimensional structures and biological functions of viral CMV PR: A New Protein Fold and Active Site
proteases is obtained, unexpected protein folds and The capsid shell of herpesviruses such as human cyto-
unique control mechanisms for proteolysis are being megalovirus (CMV) assembles in a fashion reminiscent
realized. These enzymes are teaching us a great deal of bacteriophage, where scaffold proteins assemble
about the various posttranslational modifications that within the capsid core prior to viral DNA packaging and
occur during viral replication, and also about dramatic are later extruded from the mature virus. The scaffolding
variations on the theme of proteolysis. proteins are encoded by two overlapping 39 coterminal
Much like a classical Greek play, virus assembly is genes, and their proteolytic processing is performed by
restricted by three unifying rules: time, place, and action. a protease encoded within the N terminus of the larger
Each viral family may take a different approach and gene. Confirmation that herpesviruses code for serine
choose an alternate path to arrive at the final infectious proteases came from studies in both herpes simplex
and CMV, where active site labeling reagents and muta-product, but all are restricted by a set of overriding rules:
genesis experiments identified a conserved serine. Al-timeÐthere is a chronology of events during the viral
though extensive sequence homology exists amonglife cycle; placeÐthe proteolytic activity is localized to
proteases from all herpesviruses, none can be discerneda specific cellular micro-environment; and actionÐthe
when compared to known serine proteases. The recentsite of substrate cleavage is highly specific.
elucidation of the CMV PR structure revealed a pre-Not all viruses encode a protease (PR), but those that
viously unseen fold and indicated the use of a noveldo ensure that proteolytic action occurs at the proper
active site (Qiu et al., 1996). The CMV PR monomertime and place, independent of the host for this essential
consists of a single b-barrel structure instead of thefunction. In general, these viruses express polyproteins
usual two b-barrel fold of proteases in the chymotrypsinthat are precisely cleaved by the viral protease(s) during
family (Figure 1A). The seven-stranded b barrel is sur-replication and particle assembly. This mode of post-
rounded by seven a helices and a signature consensustranslational modification serves several purposes: teth-
sequence flanking the active site serine is not found.ered proteins can travel together to the proper assembly
The structure reveals a novel catalytic triad of His/His/site, enzyme activation is delayed until folding and as-
Ser instead of the well-characterized Asp/His/Ser ofsembly begins, and regulation of proteolysis can control
known serine proteases. Superposition of the chymo-the concentration of key viral proteins. Equally important
trypsin and CMV PR structures revealsa similar position-is the role of the protease in mediating virus assembly/
ing of the side chains of the activesite residues, strongly
disassembly by converting uncleaved, assembled poly-
suggesting an independent evolutionary pathway con-
proteins into mature capsids capable of disassembling
verging to yield similar enzymatic function.
upon virus entry into a newly infected cell. All of these Kinetic studies using oligopeptide substrates show a
events may serve to optimize infectious virus production very poor turnover rate for the CMV PR, on the order of
by orchestrating the processes of replication and viral 104 lower than the digestive serine proteases (Table 1).
maturation. The low catalytic efficiency observed for CMV PR and
Proteases have been identified in a wide range of other herpesvirus proteases may reflect the altered ca-
viruses, with no correlation to capsid complexity, pres- talytic triad. His replacement of Asp as the third member
ence of lipid envelope, or nature of their genomes of the triad serves to position the catalytic His but does
(KraÈ usslich and Wimmer, 1988). They can be found in not increase the nucleophilicity of the eponymous Ser.
nonenveloped ssRNA viruses (picornaviruses), enve- The low turnover rate of CMV PR may be beneficial to
loped ssRNA viruses (flaviviruses, retroviruses), nonen- the virus assembly process since scaffold maturation is
veloped dsDNA viruses (adenoviruses), and also in en- a relatively slow process. Viral DNA encapsidation and
veloped dsDNA viruses (herpesviruses). Since numerous extrusion of the scaffold proteins occurs only if proteo-
human pathogens belong to these virus families, interest lytic processing occurs. If processing were too rapid,
in these enzymes is understandable. Proof that virally the coordination of these events might not be optimal,
encoded proteases are essential for viral replication and jeopardizing the production of infectious particles. There-
fore, the virus may not require a highly efficient enzyme,infectivity has led to their identification as key targets
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Table 1. Chemical, Functional, and Structural Characteristics of Selected Viral Proteases
Catalytic efficiencies are expressed as averages of kcat/Km values (M21s21) obtained using peptide substrates and are compared to an efficient
digestive enzyme (kcat/Km of 107M21s21). The preferred cleavage site on natural substrates is shown with arrows representing the scissile bond.
The amino acid number for each catalytic residue is shown above the depicted side chain.
opting instead for slower turnover and emphasizing af- (Ding et al., 1996). The active site of AVP contains a
Glu/His/Cys catalytic triad in a similar arrangement tofinity for the proper substrate sequence. The enzymati-
cally active CMV PR appears to be a dimer, as shown cysteine proteases like papain (Asn/His/Cys). The archi-
tecture of seven a helices and a single five-stranded bby preliminary biochemical and structural (Figure 1A)
analyses, suggesting yet another use of a structural mo- sheet in the central core forming a ªb-sheet sandwichº
is unique (Figure 1B). Only the central core resemblestif to regulate the timing of proteolysis.
AVP: A Cysteine Protease Active Site some of the motifs seen in the active sites of serine
or cysteine proteases, and these similarities suggest ain a Novel Protein Fold
In the case of the adenovirus protease (AVP), a cysteine notable convergence in favor of enzyme function.
The major role of AVP is to process the core proteinsprotease catalytic triad is found in a completely novel
protein fold, which also incorporates a peptide cofactor within an assembled virion in the nucleus of an infected
Figure 1. Structures of Selected Viral Proteases
Active site residues are shown in yellow, and unique macromolecular features are distinguished by different colors. (A) CMV PR. Monomers
differ in color; coordinates courtesy of W. Stallings. (B) AVP. Peptide cofactor (pVIc) is shown in red; coordinates courtesy of W. Mangel. (C)
HCV NS3 PR. A portion of the 54 amino acid cofactor is colored red; coordinates courtesy of K. Wilson and J. Thomson. HRV3C PR and SCP
also adopt this fold. (D) HIV PR. Monomers differ in color. Figure created at UCSF by J. Harris and C. S. Craik.
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cell. The apoenzyme is relatively inactive, unlikely to proteolytic activity, while 3D must be fully processed
before it is active. The proteolytic release of an activeprematurely cleave virion precursors in the cytoplasm.
An eleven amino acid peptide, identified biochemically polymerase may thereby influence virus replication. This
multifunctional activity within a single protein structureand structurally as a cofactor, is a product of the prote-
ase activity and can raise kcat by at least 300-fold. In the is not observed in eukaryotic proteases and exemplifies
the efficient use of a small viral genome.structure, this pVIc peptide appears as a sixth b strand
adjacent to the core b sheet, participating in one disul- Sindbis Core Protein: Both a Protease
and a Structural Proteinfide and numerous hydrogen bonds. It does not directly
contact any catalytic residues, but it could alter the Sindbis virus genomic RNA codes for two polyproteins
that must be posttranslationally cleaved by viral or hostactive site conformation based on its positioning. Incu-
bation of the enzyme±cofactor complex with viral DNA proteases. The p130 polyprotein consists of the Sindbis
core protein (SCP) at the N terminus, followed by threeboosts enzyme activity by at least another 20-fold, sup-
porting the idea that internal virion environment serves glycoproteins. As the first step in maturation, SCP per-
forms a single autocatalytic cis cleavage to release itselfto optimize proteolytic activity. The use of a peptide
cofactor and DNA to enhance activity can be viewed from this polyprotein, and then has no further catalytic
activity, leaving subsequent steps to other proteases.as regulatory steps, such that protease activity is not
augmented until required inside the virion. SCP self-inactivates by playing a structural trick: in-
serting its C-terminal tryptophan into the P1 substrateHRV 3C: A Serine Protease Fold
with a Cys Nucleophile binding site, thus rendering itself inactive. The inactive
structure then assembles into the icosahedrally sym-The replication of picornaviruses requires processing of
a single polyprotein encoded by the RNA genome. The metric core that surrounds the genomic RNA.
Sequence scanning of SCP identified the highly con-proteolytic steps fall into three categories: cotransla-
tional processing of capsid precursor by the 2A PR, served sequence surrounding the active site Ser in the
chymotrypsin family. Studies with temperature-sensi-protease-independent cleavage during final core matu-
ration, and liberation of nonstructural proteins by 3C PR tive mutants suggested a catalytic triad of Asp/His/Ser
for SCP that was later confirmed by crystallographicactivity. Mutagenesis and biochemical analyses indicate
that both the 2A and the 3C proteases have essential studies (Tong et al., 1993). The structure revealed a fold
very similar to chymotrypsin consisting of two b-barrelcysteine residues. Based on sequence alignments and
secondary structure predictions, it was proposed that domains flanking the substrate binding site. The com-
pact structure with short turns between the b strands3C PR folds similarly to the chymotrypsin family serine
proteases, even though it shares less than 10% se- could facilitate assembly of the core. Another unique
feature of the structure is a very basic N-terminal seg-quence identity with members of that clan (BazaÂ n and
Fletterick, 1988). The human rhinovirus (HRV) 3C struc- ment responsible for association with the viral RNA and
essential for encapsidation. SCP exemplifies a proteinture (Matthews et al., 1994) confirms that prediction and
shows that a catalytic triad of Glu/His/Cys is positioned with multiple functions that must be incorporated into
a single structure, again showing how small virusessimilarly to the Asp/His/Ser of serine proteases. This is
a Cys-active-site protease that folds into two equivalent maximize their coding capacity.
HCV NS3: A Tethered Enzymeb barrels, much like chymotrypsin, but with differences
in some connecting loops, in the precise orientation of with a Peptide Cofactor
The emergence of hepatitis C virus (HCV) as a majorcatalytic residues, and in regions required for transition
state stabilization. The enzyme did not evolve from a human pathogen has propelled the virally encoded NS3
PR into the limelight as a potential antiviral target. HCVsimple replacement of a Ser by a Cys nucleophile, but
as a concerted structure that supports the coordination translates its RNA genome into a single polyprotein pre-
cursor. The structural proteins at the N terminus areof a novel catalytic mechanism (mutagenesis of the ac-
tive site Cys for a Ser yields an enzyme with a severely processed by host proteases, while nonstructural pro-
teins at the C terminus are processed by the two virallyreduced activity). The 3C proteases are not highly active
enzymes and they may utilize a weaker Cys/His catalytic encoded proteases. NS2-3 performs a single cis cleav-
age, while NS3 cleaves at four sites to release the non-dyad, although caspases are efficient catalysts that use
a Cys/His dyad. The third member of the triad (Glu or structural viral proteins. Although it has no sequence
homology to any known protease, the NS3 protein wasAsp) is not strictly conserved among all 3C proteases,
and it is pointing away from the active site His, and thus predicted to be a serine protease based on active-site
labeling and mutagenesis studies. The predicted NS3is unlikely to assist in catalysis. However, sequestration
of picornavirus replication and assembly to smooth PR domain is physically linked at its C terminus to the
viral RNA helicase activity.membranes may compensate for reduced 3C activity
by increasing the enzyme:substrate ratio. The recently elucidated crystal structures of NS3 PR
confirm the catalytic triad residues Asp/His/Ser and, likeThe 3C PR has been shown to directly bind viral RNA
and to be important for the initiation of RNA replication. HRV 3C and SCP, it also adopts the somewhat ªuniversal
foldº of a chymotrypsin, dual b barrel (Figure 1C). OneRNA binding occurs at a region distal from the active
site, and generation of this binding domain imposes structure also confirms the presence of a peptide cofac-
tor that intercalates within the enzyme core completingstructural restrictions on this enzyme not found in other
proteases. Interestingly, 3C is found fused to the 3D a b barrel and stabilizing the N-terminal a-helix (Kim et
al., 1996). This 54 amino acid cofactor is the product ofRNA polymerase for a large portion of the viral life cycle.
Both the autoprocessed 3C and the fused 3CD have the only cis cleavage performed by NS3. Although quite
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distant fromthe catalytic triad, NS4Amay enhanceactiv- occurs on a scale much accelerated when compared to
eukaryotes, especially RNA viruses that lack proofread-ity by optimizing and rigidifying the extended substrate
binding site. The complex can aid viral assembly by ing mechanisms and can thus introduce many muta-
tions. Selection for tolerable mutations is built-in sincesubstantially increasing catalytic efficiency when pro-
cessing of the remaining nonstructural proteins is re- only viable viruses survive, expediting the search for
structures that achieve the two major constraints placedquired. Another role for the NS4A cofactor is the delivery
of NS3 PR to cellular membranes. Membrane localiza- on enzymes: preservation of catalytic competence and
structural stability.tion isa requirement for HCVcapsid assembly and matu-
ration; thus, coordination of full protease activation and Viral proteases are optimized to regulate and coordi-
nate viral replication and assembly. Unlike digestive en-membrane localization may be a regulatory step for the
virus. In vitro studies mixing NS3 and NS4A suggest zymes, they are highly selective catalysts performing
limited proteolysis. The evolved protease sequence maythat complex formation is not absolutely required for
protease activity, giving the membrane targeting role not be the most catalytically robust enzyme, but one
capable of performing proteolysis as well as other rolesof NS4A added importance in vivo. The physical link
between two unrelated enzymes as exemplified by the in viral replication. The ability of a viral protease to asso-
ciate with the viral genome, become a core protein, orNS3 protease-helicase has no precedent in the realm
of nonviral proteases. The peptide cofactor may serve accommodate a cofactor may result in structural com-
promises leading to less efficient enzymes. But colocali-to deliver these two enzymes to their requisite cellular
location. Again we see the requirements for viral replica- zation of enzyme and substrate within a virion may serve
tocompensate for reduced activityand may also impedetion dictating new structural motifs in viral enzymes.
HIV PR: Regulation of Protease Activity random hydrolysis of host proteins. Perhaps these unique
folds and structural complexities (Figure 1) may lead toby Dimerization
Retroviruses such as the human immunodeficiency virus novel antiviral designs that extend beyond active site±
directed, small molecules, selectively inhibiting these(HIV) encode a single protease. The HIV PR is responsi-
ble for the cleavage of gag and gag-pol polyproteins to enzymes while not affecting host functions (BabeÂ et al.,
1995). The uniqueness of viral proteases could becomeyield all capsid proteins and viral enzymes. Alignment
of the viral protease region with known sequences lead the ultimate ªAchilles' heelº of the virus, as seen recently
with effective HIV PR antiviral therapies.to the unorthodox suggestion that it could fold as a
single domain of an aspartic protease such as pepsin
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discovered (Figure 1). These structures encompass the
fundamental aspects of a protease: a substrate binding
cleft, a reaction center, and a mechanism for transition
state stabilization to permit catalysis (Perona and Craik,
1995). The many variations on the protein folds and
catalytic residues displayed by these enzymes (Table
1) are not surprising when their origins are examined.
Assuming that evolution will explore the limits of the
allowed protein structures that are compatible with re-
tention or acquisition of function, then viruses are partic-
ularly capable of achieving this task. Their replication
